Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank79
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-0.99
↑ 70% vs avg
Percentile
P79
Within normal range
Streak
2 yr
Consecutive growthElevated
Average
-3.33
Historical baseline
PeriodValueYoY Change
2024-0.99+64.2%
2023-2.77+64.4%
2022-7.79-56.1%
2021-4.99-17.1%
2020-4.26-187.1%
2019-1.48+14.5%
2018-1.74-4.2%
2017-1.67+4.5%
2016-1.74+70.3%
2015-5.86-